Clinical Trial Update: Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether allopurinol provides cerebral and cardiac protection to neonates with critical congenital heart disease undergoing car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: dr. M.J.N.L. Benders | Conditions: Congenital Heart Disease in Children, Neuroprotection | Phase 3 | Status: RECRUITING